Hans G. Beger – författare

Pancreatic Cancer, Cystic Neoplasms and Endocrine Tumors: Diagnosis and Management is a modern, expertly crafted and clinically focused guide to the diagnosis, management and best-practice care of patients suffering from pancreatic cancer, cystic neoplasms and endocrine tumours.Packed with outstanding figures and with reference to the leading society guidelines, its main focus is on the many endoscopic and radiologic diagnostic techniques, medical and surgical management of both full-blown cancer and other tumors, and the risks of each form of treatment.  Also covered in detail are issues of tumor recurrence and long-term outcome of treatment.Brought to you by highly skilled national and international leaders in the specialty and an experienced editor team, this is an invaluable guide to practicing gastroenterologists and surgeons in the hospital and clinical environment, as well as oncologists and endocrinologists managing patients with pancreatic tumorous lesions.

The PANCREASThe newest edition of the essential guide to pancreatic medicineThe fourth edition of The Pancreas: An Integrated Textbook of Basic Science, Medicine, and Surgery integrates the cutting-edge research of recent years to update its presentation of this fast-growing subject. It details every known disorder of the pancreas, grounding them in a thorough understanding of pancreatic function, enhanced with high quality illustration and graphs. It also includes step-by-step guidance for relevant endoscopic techniques and surgical procedures. The Pancreas readers will also find: New comprehensive insights into three pancreatic diseases: autoimmune pancreatitis, cystic neoplasms, and neuroendocrine tumorsAn editorial team with decades of clinical and research experience in the US, Europe, and AsiaOver 500 downloadable illustrations for use in scientific presentationsThe Pancreas is a foundational reference for clinicians and researchers in gastroenterology and gastrointestinal surgery.

Im Chirurgischen Forum werden ausgew{hlte Beitr{ge vorab ver|ffentlicht, dieauf dem Kongre~ der Deutschen Gesellschaft f}r Chirurgie vorgetragen werden.Der Forumsausschu~ achtet dabei auf h|chste Qualit{t der Beitr{ge. Der Leser findet hier die neuesten Ergebnisse aus Forschung und Klinik }bersichtlich in einem Band.

Viele Fragen…Intensivmedizinische Therapie der schweren akuten Pankreatitis: welche Standards heute?Evidenz zur interventionellen Therapie von Pseudozysten?Ergebnisse randomisierter Studien zur interventionellen und operativen Therapie der chronischen Pankreatitis?Bedeutung der bisher verkannten Autoimmunpankreatitis in der Differenzialdiagnose entzündlicher Pankreaserkrankungen?Gutartige zystische Neoplasien: wann systematische Überwachung, wann operieren?Endokrine Tumoren des Pankreas: Standards der Diagnostik, Überwachung und operativen Therapie.Adjuvante bzw. neoadjuvante Chemotherapie beim Pankreaskarzinom: wann und wie?Onkologische Resektion beim Pankreaskarzinom, welcher Nutzen? Effizienz der palliativen Chemotherapie?Neue therapeutische Konzepte und bessere Heilungschancen bei periampullären Karzinomen?… die präzisen Antworten der Experten finden Sie hier.

A variety of new cancer therapy modalities are discussed and evaluated in this book. It aims to demonstrate that the combination of classical chemo- and radiotherapy with new approaches in the field of immunotherapy can result in an improved treatment modality. Immunotherapy in this context consists of therapy with monoclonal antibodies, hematopoietic growth factors and other lymphokines. Results of early clinical trials with IL-2, GM-CSF and monoclonal antibodies against gastrointestinal tumors and melanoma are included. The progress in regional chemotherapy strategies, for example of the liver, is shown. In addition, the development of new chemotherapeutic agents with a different mode of action as well as better tolerability is presented. The use of hormones, such as LH-RH agonists, allows hormone-dependent tumors such as prostatic and breast cancer to be treated without strong adverse reactions. These recent findings give the reader insight into exciting therapeutic directions made possible by such combined, rather than single, modalities.